Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

A Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy Participants Who Are Obese or Overweight

← catalyst calendar

NCT06440980 · results posted

Sponsored by Eli Lilly and Company (industry) · LLY — their whole pipeline →.

Phase
Phase 1
Status
Completed
Study type
Interventional
Design
Randomized · None · Basic science
Enrollment
533actual
Sites
7
Country
United States

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
Start2024-06-24actualWhen the study began enrolling
Primary completion2025-06-02actualThe date the last participant is measured for the primary outcome — the readout window
Study completion2025-06-02actualThe whole study's end, after follow-up
First posted2024-06-04actualWhen this record first appeared on the registry
Results posted2026-07-17actualWhen the sponsor posted results to the registry
Record updated2026-07-17actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Conditions

  • Healthy
  • Obese
  • Overweight
  • Obesity

Intervention

  • Drug: Orforglipron — also filed as LY3502970

Primary outcomes

what the primary-completion date above is the date OF
Part B: Pharmacokinetics (PK): Steady-state Area Under the Concentration Time Curve From Time Zero to the End of the Dosing Interval, Tau (AUC[0-tau]) of LY3502970 on Day 7
measured Pre-dose, 0.5, 1, 2, 4, 6, 8, 12, 16 and 24 hours post-dose on Day 7 for each dosing treatment period (1 period=7 days)
Part B: PK: Steady-state Maximum Observed Concentration (Cmax) of LY3502970 on Day 7
measured Pre-dose, 0.5, 1, 2, 4, 6, 8, 12, 16 and 24 hours post-dose on Day 7 for each dosing treatment period (1 period=7 days)

Posted documents

hosted by the registry — we link, never re-serve
Study Protocolposted 2024-08-14 · 8.2 MB · Prot_000.pdf
Statistical Analysis Planposted 2025-03-10 · 1.0 MB · SAP_001.pdf

Publications

Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.

Permalink · LLY's whole pipeline · Catalyst calendar · Every registered study · What changed